Developing an antibiotic for serious gram-positive Staph infections.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/06/2009 |
Offer Price | $5.00 |
Price Range $5.00 - $5.00 | |
Offer Shares (mm) | 10.0 |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/02/2010 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $50 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Diego, CA, United States |
Founded | 2004 |
Employees at IPO | 36 |
Website www.triusrx.com |